Thought Leadership
 
Email Page
Recent FDA Court Decision Shows Potential Impact of SCOTUS Deference Decision
August 20, 2019
Chad Landmon, Alex Alfano, and Ashton Copeland
Bloomberg Law and Bloomberg Big Law Business

Axinn partner Chad Landmon, associate Alex Alfano, and summer associate Ashton Copeland authored the Bloomberg Law article, "Recent FDA Court Decision Shows Potential Impact of SCOTUS Deference Decision." This article was also published in Bloomberg Big Law Business.

Click here to access the article.